EUVIMEDEUVIMED entdecken
Crossref

MFG‐E8 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells through GSK3β/β‐catenin signaling pathway

Jinwu Bai, Weijun Zhang, Chenwei Zhou, Guangfeng Zhao, Huiming Zhong, Kai Hang, Jianxiang Xu, Wei Zhang, Erman Chen, Jiaqi Wu, Ling Liu, Deting Xue

The FASEB Journal · 2023

DOI: 10.1096/fj.202201417rrr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Jinwu Bai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, People's Republic …. Hauptthemen laut MEDLINE: Osteogenesis, Mesenchymal Stem Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fracture nonunion and bone defects are challenging for orthopedic surgeons. Milk fat globule‐epidermal growth factor 8 (MFG‐E8), a glycoprotein possibly secreted by macrophages in a fracture hematoma, participates in bone development. However, the role of MFG‐E8 in the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) is unclear. We investigated the osteogenic effect of MFG‐E8 in vitro and in vivo. The CCK‐8 assay was used to assess the effect of recombinant human MFG‐E8 (rhMFG‐E8) on the viability of hBMSCs. Osteogenesis was investigated using RT‐PCR, Western blotting, and immunofluorescence. Alkaline phosphatase (ALP) and Alizarin red staining were used to evaluate ALP activity and mineralization, respectively. An enzyme‐linked immunosorbent assay was conducted to evaluate the secretory MFG‐E8 concentration. Knockdown and overexpression of MFG‐E8 in hBMSCs were established via siRNA and lentivirus vector transfection, respectively. Exogenous rhMFG‐E8 was used to verify the in vivo therapeutic effect in a tibia bone defect model based on radiographic analysis and histological evaluation. Endogenous and secretory MFG‐E8 levels increased significantly during the early osteogenic differentiation of hBMSCs. Knockdown of MFG‐E8 inhibited the osteogenic differentiation of hBMSCs. Overexpression of MFG‐E8 and rhMFG‐E8 protein increased the expression of osteogenesis‐related genes and proteins and enhanced calcium deposition. The active β‐catenin to total β‐catenin ratio and the p‐GSK3β protein level were increased by MFG‐E8. The MFG‐E8‐induced enhanced osteogenic differentiation of hBMSCs was partially attenuated by a GSK3β/β‐catenin signaling inhibitor. Recombinant MFG‐E8 accelerated bone healing in a rat tibial‐defect model. In conclusion, MFG‐E8 promotes the osteogenic differentiation of hBMSCs by regulating the GSK3β/β‐catenin signaling pathway and so, is a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisMesenchymal Stem CellsHumansRatsAnimalsbeta CateninFactor VIIIGlycogen Synthase Kinase 3 betaSignal TransductionCell DifferentiationGlycoproteinsCells, CulturedWnt Signaling PathwayBone Marrow CellsGlycolipidsLipid Droplets

Stichwörter der Autor:innen

MFG-E8Wnt/beta-cateninhBMSCsosteogenesisosteogenic differentiation

Substanzen

beta CateninFactor VIIIGlycogen Synthase Kinase 3 betaGlycoproteinsmilk fat globuleGlycolipids

Autor:innen und Institutionen

  • Department of Orthopaedics, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Orthopedics Research Institute, Zhejiang University, Hangzhou, People's Republic of China.
  • Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou City, Zhejiang Province, PR China.
  • Clinical Research Center of Motor System Disease of Zhejiang Province, Hangzhou City, Zhejiang Province, PR China.
  • Department of Emergency, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Department of Nephrology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Bai, J., Zhang, W., Zhou, C., Zhao, G., Zhong, H., Hang, K., Xu, J., Zhang, W., Chen, E., Wu, J., Liu, L., & Xue, D. (2023). MFG‐E8 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells through GSK3β/β‐catenin signaling pathway. The FASEB Journal. https://doi.org/10.1096/fj.202201417rrr

Vancouver

Bai J, Zhang W, Zhou C, Zhao G, Zhong H, Hang K, et al. MFG‐E8 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells through GSK3β/β‐catenin signaling pathway. The FASEB Journal. 2023. doi:10.1096/fj.202201417rrr

BibTeX
@article{Bai2023,
  author = {Bai, Jinwu and Zhang, Weijun and Zhou, Chenwei and Zhao, Guangfeng and Zhong, Huiming and Hang, Kai and Xu, Jianxiang and Zhang, Wei and Chen, Erman and Wu, Jiaqi and Liu, Ling and Xue, Deting},
  title = {MFG‐E8 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells through GSK3β/β‐catenin signaling pathway},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202201417rrr}
}
Kostenlos starten →